Apple to Increase Covid Testing for Vaccinated Retail Employees
(Bloomberg) -- Apple Inc. plans to begin testing vaccinated retail staff twice a week for Covid-19, a step toward dropping its mask requirement for employees.
The company announced the plan in a memo to U.S. retail staff Tuesday, changing a policy that had required vaccinated workers to test once a week. Unvaccinated staff had already been required to test twice weekly. At the same time, the company is now allowing employees to verify their results independently rather than providing proof.
“Based on what we've learned from our testing pilot, everyone will now be required to self-test twice per week, regardless of vaccination status,” the company said in the memo. “In addition, if you were submitting your test results for verification, you're no longer required to do so.”
Apple also said in the memo that it is reconsidering the mask requirement for employees and that an update will be shared soon. “At this point, team members should continue to wear a face mask in store,” according to the memo. The company is “currently reviewing our face mask guidance for team members.”
Apple, based in Cupertino, California, told employees that while it may need to adjust the protocols again in the future, the company is “hopeful that case numbers remain low and these protocols will be in effect for the foreseeable future.”
Apple has been gradually loosening its Covid-19 rules. The company recently dropped its mask mandate for customers in most stores across the country -- in line with changing rules on indoor mask wearing from local governments and the U.S. Centers for Disease Control and Prevention. It's also preparing to bring back in-store Today at Apple classes.
Though cases are falling, the company has yet to announce a new return-to-office deadline for corporate employees. Apple had previously planned to require staff to work from the office at least three days per week by Feb. 1, but that plan was delayed after the omicron variant caused a spike in cases.
©2022 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
